According to Dr. Karolina Armonaitė, a neuroscientist from Kaunas University of Technology in Lithuania, a more precise understanding of what happens in different areas of the cerebral cortex during ...

We read with great interest the Article by Randall J Bateman and colleagues investigating long-term gantenerumab treatment in dominantly inherited Alzheimer's disease.1 This important work provides ...

Recently, the team led by Chief Physician Quan Zhang and Associate Professor Feng Liu at Tianjin Medical University General Hospital systematically evaluated the genetic associations between type 2 ...

A novel MRI-based ‘aging’ clock may offer a simple way to identify patients whose biological age is outpacing their ...

Dementia, as a clinical diagnosis, is largely a disease of deficit—impairments of memory, orientation, judgment, and executive functioning.

ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including ...

An autopsy study of a 45-year-old former U.S. Navy crewman with severe chronic traumatic encephalopathy (CTE) suggested that repetitive high-speed boat impacts with waves can contribute to CTE. ( JAMA ...

Imagine a tool to measure how fast you’re aging… while you’re still reasonably healthy. From a single MRI of your head, researchers can measure your aging rate and predict your ...

ObjectivesThis study aims to analyze the prevalence, impact, and disparities of Alzheimer's disease and other dementias (ADRD) among adults aged 65 years and ...

Background Beta-synuclein is an emerging blood biomarker for detecting synaptic damage in Alzheimer’s disease (AD) but its role in early AD as well as in other dementias is unclear. Methods We ...

Where you live in the U.S. may influence dementia risk, with a growing body of evidence showing regional differences in rates among older veterans.